THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE

被引:101
作者
BERTILSSON, L [1 ]
ABERGWISTEDT, A [1 ]
机构
[1] DANDERYD HOSP,PSYCHIAT UNIT,S-18288 DANDERYD,SWEDEN
关键词
D O I
10.1111/j.1365-2125.1983.tb01518.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:388 / 390
页数:3
相关论文
共 10 条
[3]   PREDICTION OF STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE FROM SINGLE ORAL DOSE KINETICS - STUDY IN TWINS [J].
ALEXANDERSON, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) :44-53
[4]   PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].
BERTILSSON, L ;
DENGLER, HJ ;
EICHELBAUM, M ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155
[5]  
HAMMER W, 1969, CLIN PHARMACOL THER, V10, P44
[6]  
HAMMER WOLFGANG, 1967, LIFE SCI, V6, P1895, DOI 10.1016/0024-3205(67)90218-4
[7]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[8]   E-10-HYDROXYLATION AND Z-10-HYDROXYLATION OF NORTRIPTYLINE - RELATIONSHIP TO POLYMORPHIC DEBRISOQUINE HYDROXYLATION [J].
MELLSTROM, B ;
BERTILSSON, L ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :189-193
[9]   ACTIVE METABOLITES OF IMIPRAMINE AND DESIPRAMINE IN MAN [J].
POTTER, WZ ;
CALIL, HM ;
SUTFIN, TA ;
ZAVADIL, AP ;
JUSKO, WJ ;
RAPOPORT, J ;
GOODWIN, FK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (03) :393-401
[10]  
POTTER WZ, 1981, HDB BIOL PSYCHIATRY, V6, P71